Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

por Subudhi, Sumit K, Aparicio, Ana, Gao, Jianjun, Zurita, Amado, John, Araujo, Logothetis, Christopher, Rao, Brinda, Vence, Luis, Allison, James, Emerson, Ryan O, Yusko, Erik, Vignali, Marissa, Robins, Harlan, Sun, Jing Jing, Sharma, Padmanee
Publicado 2015